Corrigendum: The effects of pemafibrate and Omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)
oleh: Yasutaka Takeda, Ichiro Sakuma, Shinya Hiramitsu, Mizuho Okada, Shinichiro Ueda, Masaru Sakurai
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2023-03-01 |
Deskripsi
Subjek
apolipoprotein B-48; atherosclerotic cardiovascular disease; residual risk; hypertriglyceridemia; pemafibrate; polyunsaturated fatty acids